BACE-1 inhibitors part 3: Identification of hydroxy ethylamines (HEAs) with nanomolar potency in cellsPaul Beswick, Gareth Wayne, G. Maile et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 58
BACE-1 inhibitors part 2: Identification of hydroxy ethylamines (HEAs) with reduced peptidic characterBrian Clarke, Gareth Wayne, Emmanuel H. Demont et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 57
BACE-1 inhibitors Part 1: Identification of novel hydroxy ethylamines (HEAs)Brian Clarke, Gareth Wayne, Emmanuel H. Demont et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 47
Abstract 2162: Inhibition of GPR65 counteracts low pH induced immunosuppressive polarization of macrophages: In vitro and in vivo characterization of potent, selective and orally bioavailable small molecule GPR65 antagonistsBarbara Cipriani, Stuart W. Hughes, Alan Naylor et al.|Cancer Research|2022Cited by 6
Abstract 668: The translational biology of small molecule GPR65 inhibitors: shared effects between mouse models and human primary tumors highlight the unique transformative potential of targeting a genetically validated innate immune checkpointBarbara Cipriani, Stuart W. Hughes, Alastair Corbin et al.|Cancer Research|2023Cited by 3